Region:
All editions →MethodologyUpdated · November 2026
Africa Regulatory Framework

Kenya + Pharmacy and Poisons Board — research peptide import reality

Kenya's Pharmacy and Poisons Board (PPB) regulates pharmaceuticals under the Pharmacy and Poisons Act (Cap 244, Laws of Kenya). KEBS (Kenya Bureau of Standards) handles import standards verification. M-Pesa is the dominant local payment system but rarely accepted by international peptide vendors. This article documents the practical Kenya reality.

PPB was established under the Pharmacy and Poisons Act (Cap 244, Laws of Kenya) and operates as the registration and regulatory authority for pharmaceuticals in Kenya. PPB requires registration of every pharmaceutical product entering Kenya. Research peptides without PPB registration are unregistered drugs under the Act. KEBS (Kenya Bureau of Standards) handles import standards verification under the KEBS Act.

For research peptide shipments specifically, PPB cooperation with Kenya Customs (Kenya Revenue Authority Customs) follows standard pharmaceutical-class import review. PeptideGuide has no data on clearance times, inspection rates or how Kenyan enforcement compares with other regulators.

For payment rails, Kenya is dominated by M-Pesa for local transactions. M-Pesa works for in-country peptide ordering (if domestic vendors existed, which they don't) but is rarely accepted by international vendors. PeptideGuide has no data on how often cards issued by Kenyan banks are declined by international peptide vendors; the KES exchange rate can move significantly.

PeptideGuide has no data on clearance times or interception rates by courier or origin for Kenya.

PPB's import guideline (CEO/EIU/GUD/051, revision 2, effective 27 February 2026) provides a prescription import permit for medicines for personal use. It is limited to a three-month supply, needs a prescription from a duly registered medical doctor (or a duty-of-care or compassionate-use letter), and is applied for by a pharmaceutical company with a wholesale dealer's licence that the patient, doctor or hospital appoints. A research-use-only purchase without a prescription does not meet these requirements.

For institutional researchers, PPB's clinical trials and research import permit covers investigational health products, reagents and chemicals imported for clinical trials and research studies. It needs an Expert Committee on Clinical Trials approval or a NACOSTI authorisation certificate and/or institutional ethics committee approval, and the registration of the institution where the research takes place (PPB guideline). PeptideGuide has no data on how Kenyan universities use it.

For non-institutional Kenyan researchers, PPB enforces against unregistered imports and PeptideGuide has no data on which courier or origin clears Kenyan customs most reliably. Cryptocurrency is a fallback when card payments fail.

Plain-language summary
PPB enforces against unregistered imports; PeptideGuide has no data on which courier or origin clears Kenyan customs most reliably. Institutional research imports need PPB's clinical trials and research import permit.
Verdict

✓Pros

  • PPB publishes a research import permit for registered institutions with NACOSTI or ethics approval

×Cons

  • PPB enforces against unregistered pharmaceutical imports
  • No Kenya-domestic peptide vendors
  • M-Pesa not accepted by international peptide vendors
  • KES exchange-rate moves add cost variability
Legal status
PPB regulates pharmaceuticals under Pharmacy and Poisons Act. Research peptides without PPB registration are unregistered drugs. Personal imports need PPB's prescription import permit (up to a three-month supply, on a prescription, applied for through a licensed wholesaler). KEBS handles import standards verification. Research imports need PPB's clinical trials and research import permit, with NACOSTI or ethics approval.
FAQ
Are research peptides legal in Kenya?

Research peptides without PPB registration are unregistered drugs under Kenyan law. PPB's personal-use route is a prescription import permit for up to a three-month supply, so a purchase without a prescription does not qualify. Research imports need PPB's clinical trials and research import permit, which requires NACOSTI or ethics approval and a registered institution.

Can I use M-Pesa for international peptide orders?

No — PeptideGuide's vendor records list no international peptide vendor that accepts M-Pesa. PeptideGuide also has no data on how often Kenyan-issued cards are declined; each vendor's accepted payment methods are listed on its vendor page.

Will PPB intercept my shipment at Nairobi airport?

PeptideGuide has no data on how often parcels are referred to PPB, on clearance times, or on differences by declaration or origin.

Are there Kenya-domestic peptide vendors?

No — there are currently no Kenya-domestic research peptide vendors that PeptideGuide tracks. All Kenya-bound shipping is cross-border.

What about institutional research at Kenyan universities?

PPB's clinical trials and research import permit covers reagents and chemicals imported for research studies, for a registered institution with NACOSTI authorisation or ethics committee approval (PPB guideline). PeptideGuide has no data on how the University of Nairobi, Kenyatta or Strathmore use it.

How does PPB compare to NAFDAC and SAHPRA?

PeptideGuide has no data comparing PPB enforcement with NAFDAC's or EDA's. South Africa differs mainly in having a domestic vendor base, although SAHPRA's May 2026 notice names BPC-157 and other research peptides as illegally marketed there.

Related research

More from this region.

Other articles covering this region's vendors, regulatory framework, and research peptides.

Africa vendor rankings
Best Africa peptide vendor 2026 — methodology-first ranking
Africa vendor brand reviews
Reschem full review 2026 — Johannesburg-based, ZAR pricing, SA-domestic fast
Africa Regulatory Framework
SAHPRA + research peptides — South Africa's pharmaceutical-import framework
Africa Regulatory Framework
SARS customs duties on imported peptides into South Africa
Healing and Regeneration Research
Accelerating tissue repair and wound healing in preclinical models
Muscle Growth Research
Investigating satellite cell activation and hypertrophic signalling in skeletal muscle
Errata · public correction log
  • 2026-11-02Earlier versions said a PPB personal-use exception requires the substance to be approved as a therapeutic good elsewhere, that universities maintain commercial-scale procurement with PPB clearance, that Kenyan bank cards typically clear with international peptide vendors, and that cryptocurrency is increasingly used as a fallback. PeptideGuide found no source for these claims; they were removed. The page now states PPB's import guideline (revision 2, effective February 2026): a prescription import permit for personal use and a clinical trials and research import permit.
  • 2026-11-01Earlier versions still called UK-origin parcels via DHL Express the lowest-friction path to Kenya, although the 2026-10-08 correction had withdrawn that claim, called Posta Kenya unreliable, and called PPB's cooperation with Kenyan customs "moderately developed". PeptideGuide holds no data comparing couriers or postal services and found no source for the cooperation claim; the claims were removed.
  • 2026-10-13Earlier versions put KES volatility at 5–10% over three months. PeptideGuide holds no data for that figure; it was removed.
  • 2026-10-08Earlier versions said research-class shipments typically clear Kenyan customs in 5–8 business days (DHL in 4–7 at Nairobi), that a UK-origin vendor with DHL is the operationally cleanest combination with the lowest customs friction, and that PPB enforcement is less aggressive than NAFDAC's or SFDA's and more rigorous than (or comparable to) Egypt's. PeptideGuide holds no data to support these claims and removed them.